MedTrace Logo

Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young Patients

NCT02585986 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2016-09-13

No results posted yet for this study

Summary

The aim of the study is to evaluate the beneficial effect of a probiotic preparation with an antiinflammatory and modulating activity on immunological processes, with positive results on different inflammatory and atopic conditions.

Conditions

  • Dermatitis, Atopic

Interventions

DIETARY_SUPPLEMENT

Probiotic

daily intake of 1 capsule probiotic

DIETARY_SUPPLEMENT

Placebo

daily intake of 1 capsule containing placebo

Sponsors & Collaborators

  • Korott, S.L.

    collaborator INDUSTRY

  • Biopolis S.L.

    lead INDUSTRY

Principal Investigators

  • Vicente Navarro-López, MD · Universidad Católica San Antonio de Murcia

  • Ana A. Ramirez-Boscá, MD · Universidad Católica San Antonio de Murcia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-07-31
Completion
2016-08-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02585986 on ClinicalTrials.gov